PENILE CANCER
Clinical trials for PENILE CANCER explained in plain language.
Never miss a new study
Get alerted when new PENILE CANCER trials appear
Sign up with your email to follow new studies for PENILE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets HPV-Driven cancers in phase II trial
Disease control Not yet recruitingThis phase II trial tests a combination of two drugs—SYS6026 and Enlonstobart—in people with advanced solid tumors that have spread and are linked to HPV types 16 or 18. The study aims to see if the combination is safe and shows signs of shrinking tumors. Participants must be at …
Matched conditions: PENILE CANCER
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for advanced penile cancer: drug combo targets tough cases
Disease control Not yet recruitingThis study tests a new combination of two drugs (becotatug vedotin and pucotenlimab) in 20 adults with advanced penile cancer that has spread and is EGFR-positive. Participants must have failed or be unable to tolerate chemotherapy. The goal is to see if the treatment can shrink …
Matched conditions: PENILE CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC